Nani, João Victor; Ushirohira, Juliana Mayumi; Bradshaw, Nicholas J.; Machado-de-Sousa, João Paulo 
; Hallak, Jaime Eduardo Cecilio ; Hayashi, Mirian A.
Source: Brazilian Journal of Psychiatry. Unidade: FMRP
Subjects: ESQUIZOFRENIA, BIOMARCADORES, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NANI, João Victor et al. Sodium nitroprusside as an adjunctive treatment for schizophrenia reduces the Ndel1 oligopeptidase activity. Brazilian Journal of Psychiatry, 2024Tradução . . Disponível em: https://doi.org/10.47626/1516-4446-2023-3315. Acesso em: 16 nov. 2024.APA
Nani, J. V., Ushirohira, J. M., Bradshaw, N. J., Machado-de-Sousa, J. P., Hallak, J. E. C., & Hayashi, M. A. (2024). Sodium nitroprusside as an adjunctive treatment for schizophrenia reduces the Ndel1 oligopeptidase activity. Brazilian Journal of Psychiatry. doi:10.47626/1516-4446-2023-3315NLM
Nani JV, Ushirohira JM, Bradshaw NJ, Machado-de-Sousa JP, Hallak JEC, Hayashi MA. Sodium nitroprusside as an adjunctive treatment for schizophrenia reduces the Ndel1 oligopeptidase activity [Internet]. Brazilian Journal of Psychiatry. 2024 ;[citado 2024 nov. 16 ] Available from: https://doi.org/10.47626/1516-4446-2023-3315Vancouver
Nani JV, Ushirohira JM, Bradshaw NJ, Machado-de-Sousa JP, Hallak JEC, Hayashi MA. Sodium nitroprusside as an adjunctive treatment for schizophrenia reduces the Ndel1 oligopeptidase activity [Internet]. Brazilian Journal of Psychiatry. 2024 ;[citado 2024 nov. 16 ] Available from: https://doi.org/10.47626/1516-4446-2023-3315
